We are a
ABOUT PHARMA GLOBE
Learn about our company
The Pharma Globe AG is a biopharmaceutical Swiss company focusing on research and development of innovative vaccine products, targeting unmet medical needs.
The company assets includes a late stage, low-risk pipeline of several advanced projects and broadly applicable technology platforms that already generate several product candidates. Relying on its unique pipeline, the company intends to become a major player in the vaccine world.
Total sales can be estimated in the magnitude of several Billion CHF.
The internationally renowned scientific team of Pharma Globe
consists of absolute specialists and is constantly being enlarged. Here is a small excerpt:
In a first phase, Pharma Globe AG is seeking equity to continue its research and position the company for the active marketing of its products. (Out-Licensing).
A second phase closes the circle of our investments to start with the construction of two own production sites. Thus, a large range of high-quality vaccines can be produced in-house. One location each is planned in Switzerland and in the EU area.
Within 24 to 36 months, the company can finance its cash flow by selling its own vaccines. It is important to know that there is a great shortage of vaccines worldwide. It is therefore conceivable that these ideal circumstances will allow very high sales for vaccine manufacturers, and a multiplication of the stock value is therefore likely to be possible.
This is not a public offer. See disclaimer.
INVESTMENT OPPORTUNITIES – GET IN CONTACT WITH US
Join our investors team
Pharma Globe AG
Team Vaccine Plant: +41 766 500 500